| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 151,328 | 157,238 | 155,941 | 152,068 | | Cost of Revenue | 22,132 | 45,660 |
-
| 26,190 | | | Gross Profit | 129,196 | 111,578 | 155,941 | 125,878 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 20,549 | 7,124 | 54,732 | 30,743 | | Non Recurring |
-
|
-
|
-
| 121 | | Others | 19,590 | 26,187 | 26,548 | 25,130 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 89,057 | 78,267 | 74,661 | 69,884 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,981 | 3,834 | 2,585 | 4,048 | | Earnings Before Interest And Taxes | 93,038 | 82,101 | 77,246 | 73,932 | | Interest Expense | 32,412 | 32,661 | 31,593 | 30,971 | | Income Before Tax | 60,626 | 49,440 | 45,653 | 42,961 | | Income Tax Expense | 22,808 | 18,647 | 16,928 | 15,980 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 37,818 | 30,793 | 28,725 | 26,981 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 37,818 | 30,793 | 28,725 | 26,981 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $37,818 | $30,793 | $28,725 | $26,981 |
|
0.22% Nasdaq 
Income Statement
